. 2016 Feb 13:77–145. doi: 10.1007/978-981-10-0791-0_4

Table 4.9.

Examples of vaccines on the market or in various development stages which are administered orally (oral administration) or by the nasal route (nasal)

Route of administration	Disease	Type of vaccine	Clinical phase
Oral	Poliomyelitis	Live attenuated	On market
	Typhus	Live attenuated	On market
	Cholera	Live attenuated	On market
	Acute gastroenteritis	Live attenuated	On market
	Diarrhea	Neutral/inactivated	Clinical phase III
	Dysentery	Live attenuated	Clinical phase III
	Ulcers in the digestive system, gastrointestinal cancer	Neutral/inactivated	Clinical phase I
	Anthrax	Vaccine strain	Preclinical phase
Nasal	Influenza	Live attenuated	On market
	Hepatitis Β	Vaccine strain	Preclinical phase
	Diseases of the respiratory system	Live attenuated	Preclinical phase
	Anthrax	Neutral/inactivated	Preclinical phase
	Bronchiolitis/pneumonia	Neutral/inactivated	Preclinical phase
	Cervical cancer	Neutral/inactivated	Preclinical phase
	SARS	Vaccine strain	Preclinical phase
	SARS	Vaccine strain	Preclinical phase